Daewoong Pharmaceutical Co., Ltd. Purchases China's Liaoning Baifeng for $16 Million
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 2, 2013 -- Daewoong Pharma, the largest manufacturer of prescription drugs in South Korea, will pay $16 million to acquire Liaoning Baifeng of China. Daewoong will invest another $16 million to bring Baifeng’s facilities up to EU standards by 2017. It plans to produce cephalosporin antibiotics for China and the rest of Asia at Baifeng. More details....
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
August 2, 2013 -- Daewoong Pharma, the largest manufacturer of prescription drugs in South Korea, will pay $16 million to acquire Liaoning Baifeng of China. Daewoong will invest another $16 million to bring Baifeng’s facilities up to EU standards by 2017. It plans to produce cephalosporin antibiotics for China and the rest of Asia at Baifeng. More details....
Help employers find you! Check out all the jobs and post your resume.